INVITATION TO DFDS Q4 2025 CONFERENCE CALL INVESTOR NEWS no. 04 - 9 February 2026 DFDS expects to publish the annual report and Q4 2025 review on 19 February 2026 at around 07:30 CET.... on 9 February 2026 at 9h50
Are Baby Snack Biscuits Safe? Risks of Salty, Processed Options Concerns are rising over baby snack biscuits, which experts say are often excessively salty, highly processed, and provide little nutritional... on 9 February 2026 at 8h51
Strong clinical data for Breye Therapeutics’ lead oral asset danegaptide presented at Angiogenesis, Exudation and Degeneration 2026 symposium Prof. Carl D. Regillo, MD, presented clinical data from the Phase 1b trial evaluating Breye Therapeutics’ lead candidate, danegaptide, in... on 9 February 2026 at 8h49
ESOP – shares for key employees GEVORKYAN, a.s. has launched its Employee Stock Ownership Plan (ESOP) for the first time, enabling employees to acquire company shares on preferential... on 9 February 2026 at 7h48
Share repurchase programme: Transactions of week 6 2026 The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank... on 9 February 2026 at 6h47